Solving patients with rare diseases through programmatic reanalysis of genome-phenome data
Open Access
- 1 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Human Genetics
- Vol. 29 (9), 1337-1347
- https://doi.org/10.1038/s41431-021-00852-7
Abstract
Reanalysis of inconclusive exome/genome sequencing data increases the diagnosis yield of patients with rare diseases. However, the cost and efforts required for reanalysis prevent its routine implementation in research and clinical environments. The Solve-RD project aims to reveal the molecular causes underlying undiagnosed rare diseases. One of the goals is to implement innovative approaches to reanalyse the exomes and genomes from thousands of well-studied undiagnosed cases. The raw genomic data is submitted to Solve-RD through the RD-Connect Genome-Phenome Analysis Platform (GPAP) together with standardised phenotypic and pedigree data. We have developed a programmatic workflow to reanalyse genome-phenome data. It uses the RD-Connect GPAP’s Application Programming Interface (API) and relies on the big-data technologies upon which the system is built. We have applied the workflow to prioritise rare known pathogenic variants from 4411 undiagnosed cases. The queries returned an average of 1.45 variants per case, which first were evaluated in bulk by a panel of disease experts and afterwards specifically by the submitter of each case. A total of 120 index cases (21.2% of prioritised cases, 2.7% of all exome/genome-negative samples) have already been solved, with others being under investigation. The implementation of solutions as the one described here provide the technical framework to enable periodic case-level data re-evaluation in clinical settings, as recommended by the American College of Medical Genetics.Funding Information
- EC | Horizon 2020 Framework Programme (779257, 825575, 779257, 779257, 825575)
- EC | EC Seventh Framework Programm | FP7 Health (305444, 305444)
- Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PT13/0001/0044, PT17/0009/0019, PT13/0001/0044, PT17/0009/0019)
- Ministerio de Economía y Competitividad
- Generalitat de Catalunya
- EC | European Regional Development Fund
- Instituto Nacional de Bioinformática ELIXIR Implementation Studies Centro de Excelencia Severo Ochoa
- EC | EC Seventh Framework Programm | FP7 Health
This publication has 28 references indexed in Scilit:
- Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providersGenetics in Medicine, 2017
- InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP GuidelinesAmerican Journal of Human Genetics, 2017
- A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disordersGenetics in Medicine, 2016
- From Wet‐Lab to Variations: Concordance and Speed of Bioinformatics Pipelines for Whole Genome and Whole Exome SequencingHuman Mutation, 2016
- The Ensembl Variant Effect PredictorGenome Biology, 2016
- ClinVar: public archive of interpretations of clinically relevant variantsNucleic Acids Research, 2015
- Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditionsGenetics in Medicine, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research dataThe Lancet, 2014
- OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disordersNucleic Acids Research, 2014